AUPH vs WFC · P/E 28, rev $283.1M vs P/E 15, $272.05B cap
Aurinia Pharmaceuticals Inc (AUPH) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported AUPH revenue for 2025-12-31 was $283.1M. Net income was $287.2M. Revenue was up 372.8% from 2024-12-31 to 2025-12-31. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
WFC does not have a complete income-statement cache yet.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the AUPH and WFC stock pages for the full models.
Not investment advice.